ASCO Recommends Extended Hormonal Tx W/ AIs for HR+ Postmeno

Moderators
Moderators Member Posts: 25,912

Updated ASCO Guidelines Recommend Extended Hormonal Therapy With Aromatase Inhibitors for Postmenopausal Women With Hormone-Receptor-Positive Breast Cancer
November 29, 2018

ASCO has updated its guidelines on adjuvant hormonal therapy, recommending postmenopausal women diagnosed with early-stage, node-positive, hormone-receptor-positive breast cancer be treated with hormonal therapy, including an aromatase inhibitor, for 10 years after surgery. Read more...

Comments

Categories